Paper39455282
Chronic interferon-stimulated gene transcription promotes oncogene-induced breast cancer.
Wang H and 6 others. Genes Dev, 2024. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Chronic interferon-stimulated gene transcription promotes oncogene-induced breast cancer. Papers, record 39455282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39455282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferons | Major topic |
| Breast Neoplasms | Major topic |
| MRE11 Homologue Protein | Major topic |
| Organoids | Major topic |
| Oncogenes | Major topic |
| Animals | |
| Mice | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Transcription, Genetic | |
| DNA-Binding Proteins | |
| Immunity, Innate |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH | NIH RePORTER |
| R01 GM059413 | NIGMS NIH HHS | United States | R01GM059413 | PubMed and NIH | NIH RePORTER |
| R35 GM136278 | NIGMS NIH HHS | United States | R35GM136278 | PubMed and NIH | NIH RePORTER |
| R37 GM059413 | NIGMS NIH HHS | United States | R01GM059413 | PubMed and NIH | NIH RePORTER |
| R37GM059413 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 37905095 | Chronic Interferon Stimulated Gene Transcription Promotes Oncogene Induced Breast Cancer. | https://conductscience.org/library/papers/37905095 |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25344738 | Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. | Nat Med | 2014 | https://conductscience.org/library/papers/25344738 | PubMed |
| 2 | 14691480 | Gadd45beta is important for perpetuating cognate and inflammatory signals in T cells. | Nat Immunol | 2004 | https://conductscience.org/library/papers/14691480 | PubMed |
| 3 | 32023457 | A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability. | Cell Rep | 2020 | https://conductscience.org/library/papers/32023457 | PubMed |
| 4 | 27791205 | Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents. | Oncotarget | 2016 | https://conductscience.org/library/papers/27791205 | PubMed |
| 5 | 27315476 | Modeling Development and Disease with Organoids. | Cell | 2016 | https://conductscience.org/library/papers/27315476 | PubMed |
| 6 | 36216730 | How cancer cells make and respond to interferon-I. | Trends Cancer | 2023 | https://conductscience.org/library/papers/36216730 | PubMed |
| 7 | 33060108 | Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin. | Cancer Discov | 2021 | https://conductscience.org/library/papers/33060108 | PubMed |
| 8 | 27637148 | IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively. | Immunity | 2016 | https://conductscience.org/library/papers/27637148 | PubMed |
| 9 | 10520993 | Targeted mutagenesis of Tsix leads to nonrandom X inactivation. | Cell | 1999 | https://conductscience.org/library/papers/10520993 | PubMed |
| 10 | 21393859 | Hunk is required for HER2/neu-induced mammary tumorigenesis. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21393859 | PubMed |
| 11 | 20010931 | Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. | Nat Protoc | 2009 | https://conductscience.org/library/papers/20010931 | PubMed |
| 12 | 38200309 | MRE11 liberates cGAS from nucleosome sequestration during tumorigenesis. | Nature | 2024 | https://conductscience.org/library/papers/38200309 | PubMed |
| 13 | 30833792 | A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape. | Nat Immunol | 2019 | https://conductscience.org/library/papers/30833792 | PubMed |
| 14 | 23567559 | Structural basis for termination of AIM2-mediated signaling by p202. | Cell Res | 2013 | https://conductscience.org/library/papers/23567559 | PubMed |
| 15 | 36289335 | The co-evolution of the genome and epigenome in colorectal cancer. | Nature | 2022 | https://conductscience.org/library/papers/36289335 | PubMed |
| 16 | 12556560 | DNA replication-dependent nuclear dynamics of the Mre11 complex. | Mol Cancer Res | 2003 | https://conductscience.org/library/papers/12556560 | PubMed |
| 17 | 27161491 | The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. | Nat Commun | 2016 | https://conductscience.org/library/papers/27161491 | PubMed |
| 18 | 34358560 | The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling. | J Biol Chem | 2021 | https://conductscience.org/library/papers/34358560 | PubMed |
| 19 | 33138274 | Transcriptional Regulation of Inflammasomes. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33138274 | PubMed |
| 20 | 19152864 | Using fluorophore-labeled oligonucleotides to measure affinities of protein-DNA interactions. | Methods Enzymol | 2008 | https://conductscience.org/library/papers/19152864 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42190606 | BRCA1 deficiency induces NFκB-dependent type-I interferon signaling in fallopian tube epithelial cells. | Neoplasia | 2026 | https://conductscience.org/library/papers/42190606 | PubMed |
| 40934750 | Innate immune sensing and signaling: Co-opted for genome surveillance? Implications for tumorigenesis. | DNA Repair (Amst) | 2025 | https://conductscience.org/library/papers/40934750 | PubMed |
| 39684407 | The RNA Revolution in the Central Molecular Biology Dogma Evolution. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684407 | PubMed |
| 39341078 | Effects of Vitamin D on tumor cell proliferation and migration, tumor initiation and anti-tumor immune response in head and neck squamous cell carcinomas. | Biomed Pharmacother | 2024 | https://conductscience.org/library/papers/39341078 | PubMed |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE246409 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39455282
GET https://conductscience.org/api/papers/v1/39455282/references?page=2